IBDEI0GJ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7419,0)
 ;;=K51.30^^36^367^24
 ;;^UTILITY(U,$J,358.3,7419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7419,1,3,0)
 ;;=3^Ulcerative Rectosigmoiditis,Uncomplicated
 ;;^UTILITY(U,$J,358.3,7419,1,4,0)
 ;;=4^K51.30
 ;;^UTILITY(U,$J,358.3,7419,2)
 ;;=^5008666
 ;;^UTILITY(U,$J,358.3,7420,0)
 ;;=K51.211^^36^367^25
 ;;^UTILITY(U,$J,358.3,7420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7420,1,3,0)
 ;;=3^Ulcerative Proctitis w/ Bleeding
 ;;^UTILITY(U,$J,358.3,7420,1,4,0)
 ;;=4^K51.211
 ;;^UTILITY(U,$J,358.3,7420,2)
 ;;=^5008660
 ;;^UTILITY(U,$J,358.3,7421,0)
 ;;=K51.218^^36^367^26
 ;;^UTILITY(U,$J,358.3,7421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7421,1,3,0)
 ;;=3^Ulcerative Proctitis w/ Other complication
 ;;^UTILITY(U,$J,358.3,7421,1,4,0)
 ;;=4^K51.218
 ;;^UTILITY(U,$J,358.3,7421,2)
 ;;=^5008664
 ;;^UTILITY(U,$J,358.3,7422,0)
 ;;=K51.20^^36^367^27
 ;;^UTILITY(U,$J,358.3,7422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7422,1,3,0)
 ;;=3^Ulcerative Proctitis,Uncomplicated
 ;;^UTILITY(U,$J,358.3,7422,1,4,0)
 ;;=4^K51.20
 ;;^UTILITY(U,$J,358.3,7422,2)
 ;;=^5008659
 ;;^UTILITY(U,$J,358.3,7423,0)
 ;;=K51.811^^36^367^28
 ;;^UTILITY(U,$J,358.3,7423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7423,1,3,0)
 ;;=3^Ulcerative Colitis,Other w/ Bleeding
 ;;^UTILITY(U,$J,358.3,7423,1,4,0)
 ;;=4^K51.811
 ;;^UTILITY(U,$J,358.3,7423,2)
 ;;=^5008688
 ;;^UTILITY(U,$J,358.3,7424,0)
 ;;=K51.818^^36^367^29
 ;;^UTILITY(U,$J,358.3,7424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7424,1,3,0)
 ;;=3^Ulcerative Colitis,Other w/ Other complication
 ;;^UTILITY(U,$J,358.3,7424,1,4,0)
 ;;=4^K51.818
 ;;^UTILITY(U,$J,358.3,7424,2)
 ;;=^5008692
 ;;^UTILITY(U,$J,358.3,7425,0)
 ;;=K51.80^^36^367^30
 ;;^UTILITY(U,$J,358.3,7425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7425,1,3,0)
 ;;=3^Ulcerative Colitis,Other,Uncomplicated
 ;;^UTILITY(U,$J,358.3,7425,1,4,0)
 ;;=4^K51.80
 ;;^UTILITY(U,$J,358.3,7425,2)
 ;;=^5008687
 ;;^UTILITY(U,$J,358.3,7426,0)
 ;;=B25.8^^36^367^31
 ;;^UTILITY(U,$J,358.3,7426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7426,1,3,0)
 ;;=3^Cytomegaloviral colitis
 ;;^UTILITY(U,$J,358.3,7426,1,4,0)
 ;;=4^B25.8
 ;;^UTILITY(U,$J,358.3,7426,2)
 ;;=^5000559
 ;;^UTILITY(U,$J,358.3,7427,0)
 ;;=M07.69^^36^367^32
 ;;^UTILITY(U,$J,358.3,7427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7427,1,3,0)
 ;;=3^Enteropathic arthropathies,Multiple sites
 ;;^UTILITY(U,$J,358.3,7427,1,4,0)
 ;;=4^M07.69
 ;;^UTILITY(U,$J,358.3,7427,2)
 ;;=^5010169
 ;;^UTILITY(U,$J,358.3,7428,0)
 ;;=M07.68^^36^367^33
 ;;^UTILITY(U,$J,358.3,7428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7428,1,3,0)
 ;;=3^Enteropathic arthropathies,Vertebrae
 ;;^UTILITY(U,$J,358.3,7428,1,4,0)
 ;;=4^M07.68
 ;;^UTILITY(U,$J,358.3,7428,2)
 ;;=^5010168
 ;;^UTILITY(U,$J,358.3,7429,0)
 ;;=L52.^^36^367^34
 ;;^UTILITY(U,$J,358.3,7429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7429,1,3,0)
 ;;=3^Erythema nodosum
 ;;^UTILITY(U,$J,358.3,7429,1,4,0)
 ;;=4^L52.
 ;;^UTILITY(U,$J,358.3,7429,2)
 ;;=^42065
 ;;^UTILITY(U,$J,358.3,7430,0)
 ;;=L88.^^36^367^35
 ;;^UTILITY(U,$J,358.3,7430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7430,1,3,0)
 ;;=3^Pyoderma gangrenosum
 ;;^UTILITY(U,$J,358.3,7430,1,4,0)
 ;;=4^L88.
 ;;^UTILITY(U,$J,358.3,7430,2)
 ;;=^186812
 ;;^UTILITY(U,$J,358.3,7431,0)
 ;;=E85.4^^36^368^2
 ;;^UTILITY(U,$J,358.3,7431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7431,1,3,0)
 ;;=3^Amyloidosis,Localized
